Vinayak Doraiswamy, Chief Scientific Officer at AtriCure, Inc. (ATRC), sold 5,000 shares at $29.83 ($149K) on 2026-03-12, disclosed to the SEC on 2026-03-16.
Seasonal sale ($149k) by Chief Scientific Officer — this insider has traded ATRC in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ATRC | SELL | 2025-08-07 | $91K | — | Filing → |
| ATRC | SELL | 2025-05-30 | $84K | — | Filing → |
| ATRC | SELL | 2022-09-19 | $458K | — | Filing → |